Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.23.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
Accounts receivable, allowance doubtful accounts $ 21,229 $ 25,773
Allowances for mortgage recievable, current 196,550 16,825
Mortgages receivable, allowance noncurrent $ 0 $ 187,170
Series B convertible redeemable preferred stock, par value $ 0.01 $ 0.01
Series B convertible redeemable preferred stock, shares designated 902,670 902,670
Series B convertible redeemable preferred stock, shares issued 0 0
Series B convertible redeemable preferred stock, shares outstanding 0 0
Series B convertible redeemable preferred stock, shares avialable for issuance 0 0
Preferred stock, shares authorized 902,670 902,670
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 150,000,000 150,000,000
Common stock, shares issued 3,653,401 823,496
Common stock, shares outstanding 3,653,120 823,215
Treasury stock, shares 281 281
Related Party [Member]    
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
Accounts receivable, allowance doubtful accounts $ 339,503 $ 339,503